Fostamatinib
Records for this ingredient, by country (identity only).
ATC B02BX09 · 6 markets · 11 records
GB 2 records · 2 shown of 2
- 150 mgtabletTavlesse 100mg tablets
- 100 mgtabletTavlesse 100mg tablets
ES 2 records · 2 shown of 2
- 150 mgtabletTavlesse 100mg tablets
- 100 mgtabletTavlesse 100mg tablets
FR 2 records · 2 shown of 2
- 189.3 mgtabletTAVLESSE 100 mg, comprimé pelliculé
- 126.2 mgtabletTAVLESSE 100 mg, comprimé pelliculé
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | ES | EU | FR |
|---|---|---|---|---|---|---|
| 150 mg tablet | TAVALISSE | Tavlesse 100mg tablets | TAVALISSE | Tavlesse 100mg tablets | ||
| 100 mg tablet | TAVALISSE | Tavlesse 100mg tablets | TAVALISSE | Tavlesse 100mg tablets | ||
| 189.3 mg tablet | TAVLESSE 100 mg, comprimé pelliculé | |||||
| 126.2 mg tablet | TAVLESSE 100 mg, comprimé pelliculé | |||||
unknown | Tavlesse 100mg tablets |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
3 more strength/form rows are recorded only in EU · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en EU · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 EU · FR 有记录（未在本表显示）。 另有 3 個規格/劑型僅在 EU · FR 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.